The induction of core pluripotency master regulators in cancers defines poor clinical outcomes and treatment resistance
收藏干细胞与再生医学数据中心2022-02-20 更新2024-03-06 收录
下载链接：
http://data.iscr.ac.cn/Article?id=60107e87ac761364d7e441fda572fbbc
下载链接
链接失效反馈官方服务：
资源简介：
Clinical expression of core pluripotent stem cell master regulators OCT4, SOX2 and NANOG is associated with treatment resistance and lethal cancers. We have described a novel model to induce the expression of these factors in vitro. We term this culture environment âAcquired Pluripotent Stem Cell Environment (APSCE)â and RNA-seq comparisons were made to culture in conventional serum supplemented âFull Mediaâ (FM) in human prostate (LNCaP, CWR22Rv1) and bladder (RT112) cancer cell lines. Depletion of the androgen receptor (AR) with siRNA targeting exon1(siEX1) was additionally performed in the CWR22Rv1 cell line alongside a scrambled control (siCTRL).Â
提供机构：
Queen's University Belfast
创建时间：
2022-02-20
